蛋白质组亚型丰富当前急性髓系白血病命名并反映内在发病机制与衰老
研究利用374例新诊断急性髓系白血病患者的多组学队列,整合蛋白质组、磷酸化蛋白质组、基因组、转录组和药物筛选数据,通过相似性网络融合聚类建立8个蛋白质组亚型,与最新世界卫生组织命名高度一致并增加可操作价值;同时揭示巨核细胞/血小板和免疫相关网络的老化模式,建立具有独立预后价值的造血衰老评分。
要点
- 基于374例新诊断AML多组学数据,相似性网络融合聚类建立8个蛋白质组亚型,与最新WHO命名一致并增加可操作价值。
- S2、S3、S7亚型高表达巨核细胞特征蛋白,与高龄和不良预后相关。
- 基于蛋白质组数据建立的造血衰老评分具有独立预后价值,评分越高与MDS相关AML、NPM1突变和克隆性造血相关基因突变相关。
核心结论
- 本研究提供AML衰老过程中分子回路和调控网络的概览,推进当前分类系统并提供对疾病的全面视角。
研究设计与样本
- 利用374例新诊断AML患者的多组学队列,整合蛋白质组、磷酸化蛋白质组、基因组、转录组和药物筛选数据,通过相似性网络融合聚类建立蛋白质组亚型。
主要发现
- 建立8个蛋白质组亚型:S1(CEBPA突变)、S3(骨髓增生异常相关AML)、S4(PML::RARA)、S5(NPM1突变)、S6(PML::RARA和RUNX1::RUNX1T1)、S8(CBFB::MYH11)、S2和S7(混合),与最新世界卫生组织AML命名高度一致并增加可操作价值。
- 巨核细胞/血小板和免疫相关网络刻画AML中不同的衰老模式,与近期RNA水平发现一致;磷酸化位点也显示不同的年龄相关特征。
- S2、S3和S7亚型中观察到巨核细胞特征蛋白高丰度,与高龄和患者不良预后相关。
- 基于蛋白质组数据建立具有独立预后价值的造血衰老评分,评分越高与骨髓增生异常相关AML、NPM1突变和克隆性造血相关基因突变相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Acute myeloid leukemia (AML) is a highly heterogeneous hematological malignancy that increasingly affects the older population, with its posttranscriptional landscape remaining largely elusive. Establishing a stable proteomics-based classification system and systematically screening age-related proteins and regulatory networks are crucial for understanding the pathogenesis and outcomes of AML. In this study, we leveraged a multiomics cohort of 374 patients newly diagnosed with AML, integrating proteome, phosphoproteome, genome, transcriptome, and drug screening data. Through similarity network fusion clustering, we established 8 proteomic subtypes with distinct clinical and molecular properties, including S1 (CEBPA mutations), S3 (myelodysplasia-related AML), S4 (PML::RARA), S5 (NPM1 mutations), S6 (PML::RARA and RUNX1::RUNX1T1), S8 (CBFB::MYH11), S2 and S7 (mixed), aligning well with and adding actionable value to the latest World Health Organization nomenclature of AML. Hematopoietic lineage profiling of proteins indicated that megakaryocyte/platelet- and immune-related networks characterized distinct aging patterns in AML, which were consistent with our recent findings at the RNA level. Phosphosites also demonstrated distinct age-related features. The high protein abundance of megakaryocytic signatures was observed in S2, S3, and S7 subtypes, which were associated with advanced age and dismal prognosis of patients. A hematopoietic aging score with an independent prognostic value was established based on proteomic data, where higher scores correlated with myelodysplasia-related AML, NPM1 mutations, and clonal hematopoiesis-related gene mutations. Collectively, this study provides an overview of the molecular circuits and regulatory networks of AML during the aging process, advancing current classification systems and offering a comprehensive perspective on the disease.
引用
- Cheng WY, Yi X, Wang ZY, et al. Proteomic subtypes enrich current acute myeloid leukemia nomenclature and reflect intrinsic pathogenesis alongside aging. Blood. 2025. PMID: 40829168. doi:10.1182/blood.2024027692
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。